Ivermectin in COVID-19 has been gaining more and more spotlight over the past weeks. Here we discuss a new pre-print study looking at the use of Ivermectin to treat mild to moderate COVID-19. Faster viral clearance by day 3? Check…
There have been quite a large number of clinical studies on Ivermectin in the treatment/prevention of COVID-19 and the NIH recently eliminated their recommendation against its use in COVID-19! One question has remained though, how might it work in COVID-19?…
Ivermectin Invitro antiviral activity Against a broad range of viruses HIV, dengue, influenza, Zika virus Invitro antiviral, SARS-CoV-2 activity 99.8% reduction in viral RNA after 48 h Worldwide use for treating COVID-19 About 3.7 billion doses of ivermectin have been…
In this video we will discuss Ivermectin, it’s theorized mechanisms of action, and post-acute COVID-19 also known as long haulers. This abstract remains in pre-print and thus we cannot take too much from it, but it proposes a potential role…
In this video we will discuss an article in pre-print that studied high dose ivermectin and COVID-19 viral loads. Ivermectin has a growing body of literature suggesting efficacy against COVID-19. That all started with a study done in cell culture…
In this video we will dive into a study that looked at variable dosing strategies of Ivermectin for COVID-19. This was a multicenter, double blinded, placebo controlled trial that looked at hospitalized patients with COVID-19. They had 6 different treatment…
